Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US Read more
Madrigal’s efforts for resmetirom will set tone for future launches of NASH therapies: GlobalData Read more
Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of Menkes Disease from Cyprium Read more